How did Chimerix's revenue and expenses shift in Q4 2024?

Chimerix's financial performance in Q4 2024 was characterized by a significant negative net income, primarily driven by substantial expenses that overshadowed the company's revenue. Here's a detailed analysis: 1. **Revenue**: The company reported a total revenue of $57,000 for the quarter. This figure is relatively modest and suggests that the company's primary source of income, possibly from sales or partnerships, was not substantial enough to cover its operational costs. |code|Ticker|Name|Date|Total Revenue|Total Expenses|Net Income|market_code| |---|---|---|---|---|---|---|---| |CMRX|CMRX.O|Chimerix|2024 Q1|0||-2.1869E7|185| |CMRX|CMRX.O|Chimerix|2024 Q2|129000||-2.0685E7|185| |CMRX|CMRX.O|Chimerix|2024 Q3|26000||-2.2879E7|185| |CMRX|CMRX.O|Chimerix|2024 Q4|57000||-2.2954E7|185| 2. **Expenses**: In contrast, Chimerix incurred total expenses amounting to $22.95 million during the same period. This is a substantial amount that far exceeds the company's revenue. Such a high level of expenses could be attributed to various factors, including research and development costs, administrative expenses, and potential impairment charges. 3. **Net Income**: Consequently, the company's net income for Q4 2024 was negative, with a net loss of $22.95 million. This indicates that the company operated at a loss during the quarter, primarily due to the high expenses that were not matched by the revenue generated. In summary, Chimerix's financial results for Q4 2024 reflect a company struggling with high expenses that far exceed its revenue, resulting in a significant negative net income. This situation highlights the importance of effective cost management and revenue growth strategies for the company's long-term financial health.